Michael R. Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA), filed a Form 4 on November 3, 2026, disclosing option exercises and open-market sales of Class A Ordinary Shares on October 30, 2026, pursuant to a Rule 10b5-1 plan.
John F. Paolini, Chief Medical Officer of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA), filed a Form 4 on November 3, 2026, disclosing option exercises and open-market sales of Class A Ordinary Shares on October 30 and November 2, 2026, all executed under a Rule 10b5-1 …
Director Michael David Cassens filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 239 shares of First Busey Corporation common stock on October 30, 2026, through dividend equivalent rights accrued on Deferred Stock Units.
Director Jennifer M. Grigsby filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 58 shares of First Busey Corporation common stock on October 30, 2026, through dividend equivalent rights accrued on Deferred Stock Units.
Director Karen M. Jensen of First Busey Corp /NV/ filed a statement of changes in beneficial ownership on November 3, 2026, reporting the acquisition of 229 shares of common stock on October 30, 2026, through dividend equivalent rights accrued on Deferred Stock Units.
Thomas Michael Regan, Executive Vice President of DTS at Ryder System Inc, filed a Form 4 on November 3, 2026, disclosing two transactions in Ryder common stock dated November 1 and November 2, 2026.
Director Kevin Rauckman filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 58 shares of First Busey Corporation common stock on October 30, 2026, through dividend equivalent rights accrued on Deferred Stock Units.
Director Stephen V. King filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 328 shares of First Busey Corporation common stock equivalent units on October 30, 2026.
Director Scott A. Wehrli filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 118 shares of First Busey Corporation common stock on October 30, 2026, through dividend equivalent rights accrued on Deferred Stock Units.
Director Frederic L. Kenney filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 286 shares in dividend equivalent rights on Deferred Stock Units of First Busey Corp /NV/ (NASDAQ:BUSE) on October 30, 2026.